Services

Ubiquitinated Peptides

Custom site-specific ubiquitinated peptides, Lys(GG) peptide standards, and defined ubiquitin conjugates prepared through solid-phase peptide synthesis, orthogonal protection, chemoselective ligation, purification, and analytical characterization.

Lys(GG) Peptides Monoubiquitinated Peptides Defined Linkages Stable Isotope Standards Custom Ligation

Defined Ubiquitin Chemistry for Site-Specific Peptide Research

Ubiquitination is a covalent post-translational modification in which the C-terminal carboxyl group of ubiquitin is linked most commonly to the ε-amino group of lysine through an isopeptide bond.

Because ubiquitin is a 76-residue protein modifier, ubiquitinated peptide synthesis is more complex than introducing a single modified amino acid. A successful route may require solid-phase peptide synthesis (SPPS), orthogonal lysine protection, segment ligation, controlled conjugation, and project-specific purification.

Bio-Synthesis develops defined synthetic strategies for short Lys(GG) standards, site-specific mono-ubiquitinated peptides, linkage-defined ubiquitin constructs, and multi-modified analytical standards. Route selection is based on sequence, attachment site, desired linkage, scale, additional modifications, and the analytical question being addressed.

Site-Defined Chemistry

Install the ubiquitin-derived modification at a selected lysine position.

Native or Mimic Designs

Select a native isopeptide route or a fit-for-purpose linkage mimic.

Multi-Modification Support

Combine ubiquitination with isotope labels, tags, or selected PTMs.

Analytical Confidence

Identity and purity assessed using project-appropriate analytical methods.

Native Lysine Ubiquitination

Ubiquitin Gly76 linked to a target lysine side chain.

Ubiquitin isopeptide bond to lysine A schematic shows the C-terminal glycine 76 of ubiquitin connected through an isopeptide bond to the epsilon amino group of a lysine residue in a target peptide. Ubiquitin 76-amino-acid protein modifier Gly76 Isopeptide Bond C-terminal carboxyl → Lys ε-amine K Target peptide with site-defined lysine
Modifier Ubiquitin, 76 aa
Common Acceptor Lys ε-amino group
Native Linkage Gly76 isopeptide bond
Cellular Enzymes E1 · E2 · E3 cascade
Synthetic Tools SPPS · ligation · conjugation
Proteomic Remnant Lys(GG), +114.0429 Da
Analytical interpretation: a Lys(GG) peptide models the diglycine remnant retained on ubiquitinated lysine after tryptic digestion; it is not equivalent to a full ubiquitin–peptide conjugate. The intended analytical or biological use should therefore be defined before route selection.

Two Routes to a Defined Ubiquitin Signal

Cellular ubiquitination is enzyme-driven and dynamic. Chemical synthesis provides a controlled material with a defined sequence, attachment site, and linkage architecture.

Cellular Ubiquitination

Biological installation and remodeling inside the cell.

Activation

ATP-dependent E1 activation of ubiquitin

Transfer

E2 conjugating enzymes carry activated ubiquitin

Specificity

E3 ligases influence substrate and site selection

Outcome

Dynamic mono-, multi-, linear, branched, or polyubiquitin signals

Heterogeneity

Modification state may vary across time and substrate population

Custom Chemical Synthesis

Defined route design for research standards and mechanistic studies.

Assembly

SPPS builds target peptide and synthetic segments

Site Control

Orthogonal protection exposes a selected lysine

Connection

Native or engineered chemoselective ligation strategy

Outcome

Structurally defined peptide, conjugate, chain mimic, or Lys(GG) standard

Reproducibility

Consistent site, composition, and analytical reference material

Route Selection Is Matched to Molecular Complexity

Ubiquitinated peptide projects are evaluated individually. The most appropriate route may use one method or combine several methods to reach the desired linkage, purity, and scale.

Orthogonal SPPS

Fmoc-based SPPS builds the target peptide while orthogonal lysine protection preserves one ε-amino group for selective modification.

  • Lys(GG) peptides
  • Short ubiquitin mimics
  • Multi-modified standards

Chemical Ligation

Peptide segments may be joined through native chemical ligation or related thiol-mediated approaches, followed when appropriate by desulfurization.

  • Longer synthetic constructs
  • Native backbone assembly
  • Segment-based route design

Isopeptide-Bond Formation

Project-specific auxiliaries, activated C termini, or chemoselective handles can connect ubiquitin-derived material to the selected lysine side chain.

  • Mono-ubiquitin conjugates
  • Defined linkage mimics
  • Custom architecture development

Purification & Verification

Preparative purification and analytical testing are designed around molecular size, hydrophobicity, linkage stability, and intended use.

  • Analytical HPLC
  • LC-MS or HRMS
  • Optional MS/MS mapping

Choose the Construct That Matches the Research Question

“Ubiquitinated peptide” can refer to several chemically different products. Defining the intended format at the quotation stage prevents a Lys(GG) standard from being confused with a full ubiquitin conjugate.

01

Lys(GG) Modified Peptides

Site-defined diglycine-modified lysine peptides for ubiquitination-site confirmation, targeted LC-MS, assay controls, and quantitative proteomics.

Proteomics standard
02

Monoubiquitinated Peptides

A single ubiquitin or designed ubiquitin-derived construct attached at one defined peptide lysine.

Mechanistic studies
03

Linkage-Defined Chain Mimics

Project-specific K6, K11, K27, K29, K33, K48, K63, M1, or branched architectures subject to feasibility review.

Signal decoding
04

Ubiquitin Fragments & Probes

Selected ubiquitin sequences, recognition motifs, reactive probes, or binding-region constructs for biochemical assays.

Enzyme & binding assays
05

Stable Isotope Standards

Heavy amino-acid incorporation into Lys(GG) or other ubiquitin-related peptide standards for quantitative mass spectrometry.

Quantitative LC-MS
06

Custom Ubiquitin Conjugates

Feasibility-driven designs combining site-specific ubiquitination with labels, handles, affinity tags, or selected additional PTMs.

Custom route design

Linkage Position Shapes the Ubiquitin Signal

Ubiquitin contains seven lysines and an N-terminal methionine that can support distinct chain topologies. Biological descriptions below are representative rather than exclusive.

K6

Associated with DNA-damage and mitochondrial quality-control pathways.

K11

Commonly associated with cell-cycle regulation and protein turnover.

K27

Linked to selected immune and stress-signaling pathways.

K29

Implicated in trafficking, lysosomal biology, and proteostasis.

K33

Associated with signaling and membrane-trafficking functions.

K48

Canonical proteasome-directed degradation signal.

K63

Frequently involved in signaling, DNA repair, and trafficking.

M1 / Linear

Head-to-tail ubiquitin linkage involved in immune signaling.

Design note: full linkage-defined ubiquitin chains, branched chains, and native isopeptide constructs are technically demanding. Sequence, chain length, topology, native-versus-mimic requirements, and analytical endpoints must be reviewed before feasibility and pricing are confirmed.

Extend Ubiquitinated Peptides with Complementary Chemistry

Explore modification and analytical capabilities that may be incorporated into ubiquitin-related peptide designs when the complete protecting-group, ligation, purification, and characterization strategy remains compatible.

Compatibility review: combining ubiquitination with other modifications can significantly affect route design, orthogonal protection, ligation order, solubility, purification, and analytical interpretation. Final feasibility is confirmed after sequence and construct review.

Defined Peptide Tools for Ubiquitin Biology

Construct format should be selected according to whether the study requires a site-specific analytical standard, an enzyme substrate, a binding probe, or a larger ubiquitin conjugate.

UPS

Proteasome Biology

Study recognition and turnover pathways associated with ubiquitin signals.

Ub-Omics

Ubiquitin Proteomics

Use Lys(GG) peptides for site assignment, targeted quantification, and assay controls.

DUB

Deubiquitinase Assays

Develop defined substrates and probes for linkage- or site-selective DUB studies.

E3

Ligase Research

Support substrate-recognition, ligase-specificity, and inhibitor-screening studies.

AUTO

Autophagy

Investigate ubiquitin-dependent recruitment and selective degradation pathways.

DDR

DNA Damage Response

Model selected ubiquitin signals involved in repair and chromatin-associated signaling.

IMM

Immune Signaling

Examine K63- or M1-related signaling events and ubiquitin-binding interactions.

DD

Drug Discovery

Prepare assay materials for ligases, DUBs, readers, and targeted protein degradation programs.

Define the Chemical Question Before Synthesis

Ubiquitinated peptide projects become substantially more predictable when site, linkage, topology, scale, and analytical use are specified at the beginning.

Construct Type

Confirm whether the project requires Lys(GG), full ubiquitin, a ubiquitin fragment, or a synthetic linkage mimic.

Attachment Site

Identify the modified lysine and provide numbering based on the full protein or the submitted peptide sequence.

Linkage Requirement

Specify native isopeptide linkage, linear M1 linkage, chain mimic, branched topology, or a method-development construct.

Additional Modifications

List isotope labels, affinity tags, fluorophores, other PTMs, reactive handles, and terminal modifications.

Solubility & Purification

Ubiquitin-containing constructs can show complex folding, hydrophobicity, and co-eluting impurities that affect recovery.

Analytical Endpoint

Define whether release requires routine identity and purity, high-resolution MS, MS/MS mapping, or application-specific testing.

From Feasibility Review to Analytical Release

Route design, synthesis, conjugation, purification, and testing are planned as one integrated process because each stage influences the final construct.

1
Project Review

Sequence, site, linkage, scale, and intended use

2
Route Design

SPPS, orthogonal protection, ligation, and QC plan

3
Segment Synthesis

Target peptide and required ubiquitin-derived components

4
Conjugation

Site-selective isopeptide or fit-for-purpose linkage formation

5
Purification

Preparative method matched to molecular complexity

6
QC & Release

Identity, purity, and project-specific characterization

Need Help Designing a Ubiquitinated Peptide?

Share the target sequence, modified lysine, desired construct type, linkage architecture, quantity, purity, additional PTMs, and intended analytical or biological use. Our peptide scientists can evaluate whether the project is best approached as a Lys(GG) standard, a site-specific ubiquitin conjugate, a chain mimic, or another custom construct.

Before You Submit Your Project

  • Target peptide sequence and residue numbering
  • Modified lysine site or ubiquitin linkage position
  • Lys(GG), mono-ubiquitin, polyubiquitin, or mimic design
  • Native linkage requirement versus acceptable analog
  • Additional PTMs, labels, tags, or reactive handles
  • Required quantity, purity, and formulation
  • Planned assay, LC-MS method, or biological use

How We Evaluate Your Design

We review sequence complexity, protecting-group strategy, segment length, ligation chemistry, linkage stability, solubility, purification risk, analytical detectability, and scale. When the requested route is impractical, we explain the limitation and propose a scientifically appropriate alternative.

Integrated Support from Research Scale to Manufacturing

Project controls are selected according to construct complexity, intended use, scale, and release requirements.

Scientific & Sequence Review

Feasibility assessment covering site, linkage, route, solubility, and analytical strategy before synthesis begins.

Controlled Synthesis

Documented SPPS, protection, ligation, conjugation, and purification strategy matched to the construct.

Analytical Confirmation

Identity and purity assessed by methods such as analytical HPLC, LC-MS, HRMS, or optional MS/MS.

Documentation & Scale-Up

Project-specific release documentation with pathways for research, pilot, and larger-scale manufacturing support.

ISO 9001:2015 ISO 13485:2016 GLP Support ISO 14001 Preparative HPLC Mass Spectrometry Optional Amino Acid Analysis GMP-Aligned Support

Ubiquitinated Peptides FAQ

FAQ

What is a ubiquitinated peptide?
A ubiquitinated peptide contains a defined ubiquitin-derived modification attached to a specific peptide site. Depending on the project, this may mean a full ubiquitin conjugate, a linkage-defined construct, or a Lys(GG) peptide representing the tryptic ubiquitination remnant.
How are ubiquitinated peptides synthesized?
Routes may combine Fmoc-based solid-phase peptide synthesis, orthogonal lysine protection, segment ligation, isopeptide-bond formation, chemoselective conjugation, preparative purification, and analytical characterization.
What is a Lys(GG) peptide?
A Lys(GG) peptide contains diglycine attached to the lysine ε-amino group. It models the remnant commonly retained after tryptic digestion of a ubiquitinated protein and is widely used in ubiquitin proteomics.
Is a Lys(GG) peptide the same as a full ubiquitinated peptide?
No. Lys(GG) is a small proteomic remnant standard, whereas a full ubiquitinated peptide carries ubiquitin or a larger ubiquitin-derived construct. Their size, structure, synthesis, and applications are different.
Can you prepare native isopeptide linkages?
Native or near-native linkage strategies may be possible depending on the sequence, construct size, attachment site, topology, and scale. Each project requires a feasibility review.
Which ubiquitin linkage types can be designed?
Projects may involve K6, K11, K27, K29, K33, K48, K63, M1, mixed, or branched architectures. Availability depends on the requested construct and synthetic feasibility.
Can ubiquitinated peptides contain stable isotope labels?
Yes. Heavy amino acids can be incorporated into Lys(GG) and other ubiquitin-related peptide standards for targeted quantitative LC-MS applications.
Can ubiquitination be combined with other PTMs?
Selected combinations with phosphorylation, acetylation, methylation, citrullination, glycosylation, labels, affinity tags, or click handles may be possible when the full synthetic route is compatible.
How are ubiquitinated peptides characterized?
Typical testing may include analytical HPLC and mass spectrometry. High-resolution MS, MS/MS mapping, amino acid analysis, or other project-specific methods can be considered when appropriate.
What information is needed for a quotation?
Provide the target sequence, residue numbering, modified lysine, desired ubiquitin format or linkage, quantity, purity, formulation, additional modifications, and intended application.

Recommended Reading

Selected foundational and review literature supporting ubiquitin chemistry, linkage architecture, chemical ligation, and ubiquitin-proteomics concepts discussed on this page.

  1. Hershko A, Ciechanover A. The ubiquitin system. Annual Review of Biochemistry. 1998;67:425–479.
  2. Dawson PE, Muir TW, Clark-Lewis I, Kent SBH. Synthesis of proteins by native chemical ligation. Science. 1994;266:776–779.
  3. Komander D, Rape M. The ubiquitin code. Annual Review of Biochemistry. 2012;81:203–229.
  4. Swatek KN, Komander D. Ubiquitin modifications. Cell Research. 2016;26:399–422.
  5. Kim W, Bennett EJ, Huttlin EL, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Molecular Cell. 2011;44:325–340.
  6. Udeshi ND, Svinkina T, Mertins P, et al. Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites. Molecular & Cellular Proteomics. 2013;12:825–831.

Scientific note: Ubiquitin chemistry continues to expand beyond simple lysine-linked homotypic chains. Noncanonical acceptor residues, mixed and branched chains, and dynamic chain remodeling can require specialized experimental designs. The product specification should therefore state whether the goal is a native conjugate, a linkage mimic, a proteomic remnant standard, or an assay-specific probe.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 45 years of delivering high-quality, fast, and scalable synthetic biology solutions.